Features | Partner Sites | Information | LinkXpress
Sign In
JIB
GLOBETECH PUBLISHING
GLOBETECH PUBLISHING

Microgel Insulin Delivery System Mimics Beta-Cell Action

By BiotechDaily International staff writers
Posted on 31 Jul 2013
Diabetes researchers have developed a nanotech technique to transport insulin in the bloodstream and release or sequester the hormone in response to changes in blood sugar levels.

Investigators at the University of North Carolina (Chapel Hill, USA) and their colleagues at the Massachusetts Institute of Technology (Cambridge, USA) used a one-step electrospray procedure to fabricate monodisperse microgels consisting of a pH-responsive chitosan matrix, enzyme nanocapsules, and recombinant human insulin. Glucose-specific enzymes were covalently encapsulated into the nanocapsules to improve enzymatic stability by protecting from denaturation and immunogenicity as well as to minimize loss due to diffusion from the matrix.

The microgel system swelled and released insulin when subjected to hyperglycemic conditions, as a result of the enzymatic conversion of glucose into gluconic acid and protonation of the chitosan network. The microgels acted as a self-regulating valve system by secreting insulin at basal release rates under normoglycemic conditions and at higher rates under hyperglycemic conditions.

Results published in the July 8, 2013, online edition of the journal ACS Nano revealed that in a mouse model of type I diabetes microgel-facilitated insulin release caused a reduction of blood glucose levels that lasted for more than 48 hours.

“The chitosan itself can be absorbed by the body, so there are no long term health effects,” said first author Dr. Zhen Gu, assistant professor of biomedical engineering the University of North Carolina. “We wanted to mimic the function of healthy beta-cells, which produce insulin and control its release in a healthy body, but what we have found also holds promise for smart drug delivery targeting cancer or other diseases.”

Related Links:
University of North Carolina
Massachusetts Institute of Technology



comments powered by Disqus

Channels

Genomics/Proteomics

view channel
Image: Differences in the structure of a small lung artery (top row) and heart cross section (lower row) of rodents without disease (far left column); with pulmonary hypertension (middle) and a diseased rodent treated with the HDL peptide (right). Note the much narrowed lung artery, and thick walls and larger chamber of the heart in the diseased animal and improvements with 4F peptide treatment (Photo courtesy of UCLA - University of California, Los Angeles).

Apolipoprotein A-1 Mimetic Peptide Reverses Pulmonary Hypertension in Rodent Models

A small peptide that mimics the activity of apolipoprotein A-1 (apo A-1), the main protein component of the high density lipoproteins (HDL), counteracted the effects of oxidized lipids and alleviated symptoms... Read more

Therapeutics

view channel
Image: Hair follicle (blue) being attacked by T cells (green) (Photo courtesy of Christiano Lab/Columbia University Medical Center).

Hair Restoration Method Clones Patients’ Cells to Grow New Hair Follicles

Researchers have developed of a new hair restoration approach that uses a patient’s cells to grow new hair follicles. In addition, the [US] Food and Drugs Administration (FDA) recently approved a new drug... Read more

Lab Technologies

view channel
Image: Leica Microsystems launches the inverted research microscope platform Leica DMi8 (Photo courtesy of Leica Microsystems).

New Inverted Microscope Designed to Readily Adapt to Changing Research Demands

A new inverted microscope for biotech and other life science laboratories was designed to readily accommodate modifications and upgrades to allow it to keep current with changing research demands and interests.... Read more

Business

view channel

Partnership Established to Decode Bowel Disease

23andMe (Mountain View, CA,USA), a personal genetics company, is collaborating with Pfizer, Inc. (New York, NY, USA), in which the companies will seek to enroll 10,000 people with inflammatory bowel disease (IBD) in a research project designed to explore the genetic factors associated with the onset, progression, severity,... Read more
 
Copyright © 2000-2014 Globetech Media. All rights reserved.